急性呼吸窘迫综合征患者气管切开与生活质量、精神障碍症状及重返工作无关:前瞻性DACAPO队列研究
该研究基于德国全国前瞻性观察性DACAPO队列,纳入877例存活出院的中位年龄54岁、68%为男性的ARDS患者,其中478例(54.5%)在ICU期间接受气管切开。ICU出院后3、6、12个月用问卷评估健康相关生活质量(SF-12的PCS-12与MCS-12)、抑郁(PHQ-9)、创伤后应激障碍(PTSD)、焦虑、强迫症症状及重返工作。12个月时388例(44.2%)有患者报告结局可分析(气管切开205例、未切开183例)。多变量分析显示气管切开与PCS-12、MCS-12、抑郁、PTSD、焦虑、强迫症及重返工作均无显著关联(OR的95%CI均跨1或差值类跨0)。
要点
- 在ARDS存活出院患者中,ICU期间气管切开与12个月时PCS-12(-0.73 [-3.96, 2.51])和MCS-12(-0.71 [-4.92, 3.49])均无显著关联。
- 气管切开与12个月时抑郁(OR 0.10 [-1.43, 1.64])和PTSD(OR 3.31 [-1.81, 8.43])症状无显著关联。
- 气管切开与12个月时焦虑(OR 1.26 [0.41, 3.86])和强迫症(OR 0.59 [0.05, 6.68])无显著关联。
- 气管切开与12个月时重返工作无显著关联(OR 0.71 [0.31, 1.64])。
- 877例ARDS存活出院患者中478例(54.5%)接受气管切开,12个月时388例(44.2%)完成患者报告结局问卷。
适用人群与场景
- 德国全国前瞻性观察性DACAPO队列中存活并出院的ARDS患者,平均年龄54±16岁,68%为男性。
- 12个月时患者报告结局可分析者为388例(44.2%),其中气管切开205例、未切开183例。
研究设计与关键结果
- 研究类型为前瞻性观察性德国全国DACAPO队列研究,纳入877例存活出院的ARDS患者,其中478例(54.5%)在ICU期间接受气管切开。
- 12个月时388例(44.2%)完成患者报告结局问卷,气管切开组205例、未切开组183例。
- 多变量线性回归显示气管切开与PCS-12无显著关联(-0.73 [-3.96, 2.51]),与MCS-12无显著关联(-0.71 [-4.92, 3.49])。
- 多变量分析显示气管切开与抑郁(0.10 [-1.43, 1.64])、PTSD(3.31 [-1.81, 8.43])、焦虑(1.26 [0.41, 3.86])、强迫症(0.59 [0.05, 6.68])及重返工作(0.71 [0.31, 1.64])均无显著关联(OR [95%CI])。
证据类型、等级与局限
- 证据类型为前瞻性观察性队列研究(DACAPO),临床试验注册号NCT02637011(2015年12月15日回顾性注册)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,ICU出院后长达1年,气管切开未影响ARDS幸存者的健康相关生活质量、精神障碍症状或重返工作。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a life-threatening condition that often requires prolonged mechanical ventilation. Tracheostomy is a common procedure with some risks, on the other hand with potential advantages over orotracheal intubation in critically ill patients. This study investigated the association of tracheostomy with health-related quality of life (HRQoL), symptoms of psychiatric disorders and return-to-work of ARDS survivors.
METHODS: Data were collected in the context of the prospective observational German-wide DACAPO study. Clinical and demographic patient data and treatment characteristics were obtained from the participating intensive care units (ICU). HRQoL and return-to-work were assessed using patient-reported questionnaires 3, 6 and 12 months after ICU discharge. HRQoL was measured with the Physical and Mental Component Scale of the Short-Form 12 Questionnaire (PCS-12, MCS-12). The prevalence of psychiatric symptoms (depression and post-traumatic stress disorder [PTSD]) was assessed using the Patient Health Questionnaire-9 and the Post-Traumatic Stress Syndrome-14. Physician-diagnosed anxiety and obsessive-compulsive disorder were recorded by patient self-report in the follow-up questionnaires. The associations of tracheostomy with HRQoL, psychiatric symptoms and return-to-work after 12 months were investigated by means of multivariable linear and logistic regression models.
RESULTS: Primary 877 ARDS patients (mean ± standard deviation: 54 ± 16 years, 68% male) survived and were discharged from ICU. Out of these patients, 478 (54.5%) were tracheotomised during ICU treatment. After 12 months, patient-reported outcomes could be analysed of 388 (44.2%) respondents, 205 with tracheostomy and 183 without. One year after ICU discharge, tracheostomy showed no significant association with physical or mental health-related quality of life (PCS-12: - 0.73 [- 3.96, 2.51]; MCS-12: - 0.71 [- 4.92, 3.49]), symptoms of psychiatric disorders (depression: 0.10 [- 1.43, 1.64]; PTSD: 3.31 [- 1.81, 8.43]; anxiety: 1.26 [0.41, 3.86]; obsessive-compulsive disorder: 0.59 [0.05, 6.68]) or return-to-work (0.71 [0.31, 1.64]) in the multivariable analysis (OR [95%-CI]).
CONCLUSIONS: Up to 1 year after ICU discharge, neither HRQoL nor symptoms of psychiatric disorders nor return-to-work was affected by tracheostomy. Trial registration NCT02637011 (ClinicalTrials.gov, Registered 15 December 2015, retrospectively registered).
参考来源
- Blecha S, Brandl M, Zeman F, et al. Tracheostomy in patients with acute respiratory distress syndrome is not related to quality of life, symptoms of psychiatric disorders or return-to-work: the prospective DACAPO cohort study. Ann Intensive Care. 2020. PMID: 32377963. doi:10.1186/s13613-020-00671-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。